Package 62135-459-90

Brand: terazosin

Generic: terazosin
NDC Package

Package Facts

Identity

Package NDC 62135-459-90
Digits Only 6213545990
Product NDC 62135-459
Description

90 CAPSULE in 1 BOTTLE (62135-459-90)

Marketing

Marketing Status
Marketed Since 2023-02-01
Brand terazosin
Generic terazosin
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "45adc1ec-ddd8-7c36-e063-6294a90a46a8", "openfda": {"upc": ["0362135460907", "0362135459901", "0362135458904", "0362135461904"], "unii": ["D32S14F082"], "rxcui": ["260376", "313215", "313217", "313219"], "spl_set_id": ["da4ca0f8-6888-447e-9948-d37196c5a19a"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE in 1 BOTTLE (62135-459-90)", "package_ndc": "62135-459-90", "marketing_start_date": "20230201"}], "brand_name": "Terazosin", "product_id": "62135-459_45adc1ec-ddd8-7c36-e063-6294a90a46a8", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "62135-459", "generic_name": "Terazosin", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA075614", "marketing_category": "ANDA", "marketing_start_date": "20210430", "listing_expiration_date": "20261231"}